Testing a new drug to prevent Alzheimer's disease and dementia
目的
Do any of your friends, family, or loved ones have problems remembering or have developed Alzheimer’s disease? The USC Alzheimer Disease Research Center is testing how well a drug may help to prevent the loss of memory. The research team is looking for volunteers (ages 60 to 75) who do not have signs of cognitive problems (meaning that their speech, thinking, and memory are fine compared to other people of the same age).
If you're eligible and choose to take part, you'll be one of the few people that can join the fight against Alzheimer's disease. But preventing such a disease won't happen overnight. The trial will run for between 5 and 8 years.
关键词: Alzheimer's Disease, Mild Cognitive Impairment, dementia, APOE4 genotype
研究地点
USC Keck Hospital, 1520 San Pablo Street 90033
- Men & Women
涉及什么？
-
5 years and 3 years of follow-up
-
21 visits and 11 for follow-up
-
CNP520 or placebo
-
Brain imaging
-
Heart activity measurement
-
Blood sample
-
Memory testing
-
There will be no payment for your participation.
-
USC will pay for all of the related medical expenses including transportation.
Why participate?
If you're the grandparent who spends time with their grandchildren, be the one who helps protect them from Alzheimer's disease.
合格
一定有
- Ages 60 to 75
- People who do not have signs of cognitive problems (meaning that their speech, thinking, and memory are fine compared to other people of the same age).
- Must speak and understand English or Spanish
About This Study
This research study is sponsored by Novartis, in collaboration with another pharmaceutical company named Amgen and in partnership with Banner Alzheimer’s Institute. Novartis produces the drug and provides funding to cover the costs of conducting this research study.
ClinicalTrials.gov Identifier: NCT03131453
Some of the potential benefits of being a participant in this clinical research study include:
• Having access to expert medical care for AD during the study and regular monitoring for clinical symptoms of AD, and regular health checks and health information
• Helping others with elevated risk for AD clinical symptoms by contributing to medical research
• Gaining access to new research treatments
• Getting actively involved in your health care
Study Team
For questions about this study, contact:
- Project Director Karen Dagerman
- University of Southern California Keck School of Medicine
- 323-442-7600
- adrc@med.usc.edu
- Clinical Trials Manager Mauricio Becerra
- University of Southern California Keck School of Medicine
- 323-442-7594
- mjbecerr@usc.edu
- Social Worker John Danner, LCSW
- California Keck School of Medicine
- 323-442-7600
- JohnJ.Danner@med.usc.edu
- Research Nurse Liberty Teodoro, RN
- California Keck School of Medicine
- 323-442-7600
- Liberty.Teodoro@med.usc.edu
We respect your privacy!
All the information you give us is stored in a secure, password protected database. All the information that you choose to share will be kept private and confidential. Read University of Southern California's Privacy Policy here.